Ovarian Endometrioid Adenocarcinoma Completed Phase 1 Trials for Human interleukin-2 (DB14865)

IndicationStatusPhase
DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00357448Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube CancerTreatment